Thyroid-like Follicular Renal Cell Carcinoma: An Emerging Entity

Thyroid-like follicular renal cell carcinoma is an extremely rare tumor. The tumors show a striking resemblance to well-differentiated thyroid follicular neoplasm but can be differentiated on immunohistochemistry due to lack of thyroglobulin and thyroid transcription factor 1 expression. Thyroid-like follicular renal cell carcinoma is seen in younger patients in the second to fourth decade with female preponderance. Most of the cases are asymptomatic or present with usual complaints of renal cell carcinoma such as flank pain, hematuria, or renal mass. Thyroid-like follicular renal cell carcinoma is a primary renal epithelial malignant tumor. The tumor is well encapsulated with follicular architecture comprising microfollicles and macrofollicles containing eosinophilic colloid-like material. Thyroid-like follicular renal cell carcinoma represents a rare histologic subtype of renal cell carcinoma with low malignant potential. According to the latest WHO classification 2022 of renal tumors, Thyroid like follicular renal cell carcinoma (TLFC) is put into emerging/provisional entities. These tumor types are still not part of the classification but are discussed in WHO.

Authors

Publication Details

Journal
Archives of Medicine and Health Sciences
Published
2025-05-01
DOI
https://doi.org/10.4103/amhs.amhs_269_23
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Thyroid-like Follicular Renal Cell Carcinoma: An Emerging Entity

Sarita Asotra, Kailash Chander Barwal, Himani Thakur
Archives of Medicine and Health Sciences
Renal cell carcinoma treatment
article

Thyroid-like Follicular Renal Cell Carcinoma: An Emerging Entity

Sarita Asotra, Kailash Chander Barwal, Himani Thakur
article en

Abstract

Thyroid-like follicular renal cell carcinoma is an extremely rare tumor. The tumors show a striking resemblance to well-differentiated thyroid follicular neoplasm but can be differentiated on immunohistochemistry due to lack of thyroglobulin and thyroid transcription factor 1 expression. Thyroid-like follicular renal cell carcinoma is seen in younger patients in the second to fourth decade with female preponderance. Most of the cases are asymptomatic or present with usual complaints of renal cell carcinoma such as flank pain, hematuria, or renal mass. Thyroid-like follicular renal cell carcinoma is a primary renal epithelial malignant tumor. The tumor is well encapsulated with follicular architecture comprising microfollicles and macrofollicles containing eosinophilic colloid-like material. Thyroid-like follicular renal cell carcinoma represents a rare histologic subtype of renal cell carcinoma with low malignant potential. According to the latest WHO classification 2022 of renal tumors, Thyroid like follicular renal cell carcinoma (TLFC) is put into emerging/provisional entities. These tumor types are still not part of the classification but are discussed in WHO.

Archives of Medicine and Health SciencesVol. 13(2)
Openalex Percentile: Top 73%
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Thyroid-like Follicular Renal Cell Carcinoma: An Emerging Entity — Sarita Asotra, Kailash Chander Barwal, et al. · Archives of Medicine and Health Sciences (2025) | TGRS Research Map | TGRS